运动干预对类风湿关节炎的影响:随机对照试验的系统审查和网络元分析
Yan Zhang1, Zelin He1, Zikang Yin1
1Department of Rheumatology and Clinical Immunology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Journal of pain research
|October 6, 2025
概括
这一网络元分析发现,特定的炼对类风湿性关节炎 (RA) 患者有显著的益处. 毕拉提减轻了疼痛,有氧和抵抗运动的联合减轻了早晨的硬,传统的中国运动改善了疾病活动.
科学领域:
- 类风湿病学 类风湿病学
- 运动科学 运动科学
- 基于证据的医学基于证据的医学.
背景情况:
- 类风湿性关节炎 (RA) 是一种影响关节的慢性炎症性疾病.
- 运动是 RA 治疗的常见非药物干预措施.
- 对RA的最佳运动方式需要进行比较有效性评估.
研究的目的:
- 进行网络元分析,比较各种运动干预措施对类风湿性关节炎的疗效.
- 为特定的RA症状管理确定最有效的运动类型.
主要方法:
- 在8个数据库中进行系统的文献搜索,搜索有关RA运动的随机对照试验 (RCT).
- 使用柯克兰偏差风险工具 (RoB 2) 进行质量评估.
- 网络元分析 (NMA) 使用Stata 17.0进行,结果以平均差异 (MD) 和95%可信度间隔 (CI) 呈现.
主要成果:
- 分析了34项涉及2,435名RA患者的RCT和10项运动干预措施.
- 皮拉塞斯在缓解疼痛方面表现出最高的疗效 (VAS:MD = -2.17厘米).
- 有氧运动 + 抵抗运动在减少早晨硬的持续时间方面表现出色 (MD = -8.23分钟).
- 传统的中国运动在改善疾病活动方面最有效 (DAS28-ESR:MD = -0.68分).
结论:
- 运动干预作为RA治疗的有效辅助.
- 具体的运动提供有针对性的益处:皮拉提治疗疼痛,联合有氧/抵抗治疗硬,以及传统的中国运动治疗疾病活动.
- 建议进一步进行高质量的研究来验证这些发现.
更多相关视频
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
811
04:23Author Spotlight: Using a Rabbit Model to Explore the Efficacy of Tuina in Treating Knee Osteoarthritis
Published on: August 25, 2023
2.0K
相关概念视频
01:11Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
01:21Rheumatic Heart Disease III: Medical Management
285
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
285
01:23Rheumatic Heart Disease I: Introduction
433
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
433
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
482
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
482
01:20Rheumatic Heart Disease IV: Nursing Management
268
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
268
01:20The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K